gyki 52466 has been researched along with Glioblastoma in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walczak, K | 1 |
| Deneka-Hannemann, S | 1 |
| Jarosz, B | 1 |
| Zgrajka, W | 1 |
| Stoma, F | 1 |
| Trojanowski, T | 1 |
| Turski, WA | 1 |
| Rzeski, W | 1 |
1 other study available for gyki 52466 and Glioblastoma
| Article | Year |
|---|---|
Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
Topics: Adult; Aged; Benzodiazepines; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; | 2014 |